Combination of singularly perturbed vector field method and method of directly defining the inverse mapping applied to complex ODE system prostate cancer model

References

• P.A. Abrahamsson, Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots, Asian J. Urol. 4 (2017), pp. 208–222. doi: 10.1016/j.ajur.2017.04.001
   Google Scholar
• American Cancer Society, Prostate Cancer, available at http://www.cancer.org.
   Google Scholar
• V. Bykov, I. Goldfarb and V. Gol'dshtein, Singularly perturbed vector fields, J. Phys. Conf. Ser. 55 (2006), pp. 28–44. doi: 10.1088/1742-6596/55/1/003
   Google Scholar
• V. Bykov and U. Maas, Reaction–diffusion manifolds and global quasi-linearization: Two complementary methods for mechanism reduction, Open Thermodyn. J. 7 (2013), pp. 92–100.
   Google Scholar
• G. Dimonte, A cell kinetics model for prostate cancer and its application to clinical data and individual patients, J. Theor. Biol. 264 (2010), pp. 420–442. doi: 10.1016/j.jtbi.2010.02.023
   Google Scholar
• S.E. Eikenberry, J.D. Nagy and Y. Kuang, The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model, Biol. Dir. 5 (2010), pp. 24. doi: 10.1186/1745-6150-5-24
   Google Scholar
• Q. Guo, Y. Tao and K. Aihara, Mathematical modelling of prostate tumor growth under intermittent androgen suppression with partial differential equations, Int. J. Bifurcat. Chaos Appl. Sci. Eng. 18 (2008), pp. 3789–3797. doi: 10.1142/S0218127408022743
   Google Scholar
• A.M. Ideta, G. Tanaka, T. Takeuchi and A. Kazuyuki, A mathematical model of intermittent androgen suppression for prostate cancer, J. Nonlin. Sci. 18 (2008), pp. 593–614. doi: 10.1007/s00332-008-9031-0
   Google Scholar
• T.L. Jackson, A mathematical investigation of the multiple pathways to recurrent prostate cancer: Comparison with experimental data, Neoplasia 6 (2004), pp. 679–704. doi: 10.1593/neo.04259
   Google Scholar
• T.L. Jackson, A mathematical model of prostate tumor growth and androgen-independent relapse, Discrete Contin. Dyn. Sys. Ser. B (2004), pp. 187–201.
   Google Scholar
• H.V. Jain, S.K. Clinton, A. Bhinder and A. Friedman, Mathematical modeling of prostate cancer progression in response to androgen ablation therapy, PNAS Proc. Nat. Acad. Sci. USA. 108 (2011), pp. 19701–19706. doi: 10.1073/pnas.1115750108
   Google Scholar
• D. Kirschner and J.C. Panetta, Modeling immunotherapy of the tumor–immune interaction, J. Math. Biol. 37(3) (1998), pp. 235–252. doi: 10.1007/s002850050127
   Google Scholar
• N. Kronik, Y. Kogan, M. Elishmereni, K.H. Tobias, S.V. Pavlovic and Z. Agur, Predicting outcomes of prostate cancer immunotherapy by Personalized Mathematical Models, PLoS One 5(12) (2010), pp. 1–8. doi: 10.1371/journal.pone.0015482
   Google Scholar
• S.J. Liao, The proposed homotopy analysis technique for the solution of nonlinear problems, PhD thesis, Shanghai Jiao Tong University, 1992.
   Google Scholar
• S.J. Liao, Homotopy analysis method in nonlinear differential equations, Springer, China Press, 2000.
   Google Scholar
• S.J. Liao, Beyond perturbation: Introduction to the homotopy analysis method, Chapman & Hall/CRC Press, Boca Raton, 2003.
   Google Scholar
• S.J. Liao and Y. Zhao, On the method of directly defining inverse mapping for nonlinear differential equations, Numer. Algor. 72(4) (2016), pp. 989–1020. doi: 10.1007/s11075-015-0077-4
   Google Scholar
• N. Mottet, J. Bellmunt, E. Briers, R.C.N. van den Bergh, M. Bolla, N.J. van Casteren, P. Cornford, S. Culine, S. Joniau, T. Lam, M.D. Mason, V. Matveev, H. van der Poel, T.H. Vanderkwast, O. Rouvire and T. Wiegel, European Association of Urology (EAU) Prostate Cancer Guidelines, available at http://uroweb.org/2015.
   Google Scholar
• T. Osada, T.M. Clay, C.Y. Woo, M.A. Morse and H.K. Lyerly, Dendritic cell-based immunotherapy, Int. Rev. Immunol. 25(56) (2006), pp. 377–413. doi: 10.1080/08830180600992456
   Google Scholar
• T. Portz, Y. Kuang and J.D. Nagy, A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy, Amer. Inst. Phys. 2 (2012), pp. 1–14.
   Google Scholar
• E.M. Rutter and Y. Kuang, Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer, DCDS-B 22 (2017), pp. 1001–1021. doi: 10.3934/dcdsb.2017050
   Google Scholar
• R.L. Sabado, S. Balan and N. Bhardwaj, Dendritic cell-based immunotherapy, Cell Res. Nat. 27 (2017), pp. 74–95. doi: 10.1038/cr.2016.157
   Google Scholar
• T. Shimada and K. Aihara, A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer, Math. Biosci. 214 (2008), pp. 134–139. doi: 10.1016/j.mbs.2008.03.001
   Google Scholar
• Y. Tao, Q. Guo and K. Aihara, A model at the macroscopic scale of prostate tumor growth under intermittent androgen suppression, Math. Models Methods Appl. Sci. 19 (2009), pp. 2177–2201. doi: 10.1142/S021820250900408X
   Google Scholar
• Y. Tao, Q. Guo and K. Aihara, A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor, J. Non. Sci. 20 (2010), pp. 219–240. doi: 10.1007/s00332-009-9056-z
   Google Scholar
• P. Travis and K. Yang, A mathematical model for the immunotherapy of advanced cancer, Proceedings: International Symposium on Mathematical and Computational Biology, September 2, 2012 14:40.
   Google Scholar